MFDS requests supplements for porcine islet transplant trial
By Lee, Tak-Sun | translator Alice Kang
21.08.30 12:00:58
°¡³ª´Ù¶ó
0
Central Pharmaceutical Affairs Council indicated that condition for clinical trial subjects should be clear and more safety verification data is necessary
With such an opinion issued, it seems that some time would be required before the clinical trial of a xenotransplantation product is conducted. The trial had gained much attention as being the ¡®world¡¯s first¡¯ trial on a xenotransplantation product.
On the 30th, the Ministry of Food and Drug Safety disclosed the results of the Central Pharmaceutical Affairs Council (CPAC)¡¯s ¡®Advisory meeting on the feasibility of the submitted investigato
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)